Executing Modern Clinical Trials Across Europe: Challenges and Opportunities landing page

Executing Modern Clinical Trials Across Europe: Challenges and Opportunities

Explore Europe’s evolving role in global clinical development.

As clinical trial activity grows across APAC, China, Australia, and North America, Europe is facing renewed pressure to prove where it can deliver differentiated value. Yet the region continues to offer deep scientific expertise, experienced investigators, strong academic networks, and meaningful opportunities across complex and specialist indications.

This executive summary captures insights from a BIO Europe Spring roundtable on the forces reshaping trial execution across Europe, from regulatory complexity and recruitment realities to the partnership models needed to support more effective development strategies.

This Executive Summary explores:

Why Europe’s share of global clinical trials has declined
Where Europe still holds scientific and operational strengths
How sponsors are balancing recruitment, commercial value, and regional strategy
The role of integrated partnerships in improving trial execution
What EU regulatory initiatives could mean for future competitiveness

First Name

Last Name

Company

Job Title

Country

Title Industry (copy)

State or Province

Numbers

Industry

Function

Role

Checkboxes (copy)

You agree Citeline and Novotech Pty Limited may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Novotech Pty Limited.